ArticlePediatrics2025
Risk of Bacterial Infections in Febrile Infants 61 to 90 Days Old With Respiratory Viruses.
Article in Pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
objectiveThe objective of this study was to describe the prevalence of urinary tract infections (UTIs), bacteremia, and bacterial meningitis among febrile infants aged 61 to 90 days with and without respiratory viral infections.
methodsWe used data from the Pediatric Emergency Care Applied Research Network (PECARN) Registry, comprised of pediatric visits from 17 emergency departments. Our cohort included infants aged 61 to 90 days with temperatures of at least 38°C, urinalyses/urine dipsticks and/or blood cultures, and respiratory viral testing performed between January 1, 2012, and April 30, 2024. We calculated the prevalence, with 95% CIs, of UTIs, bacteremia, and bacterial meningitis, stratified by presence and types of respiratory viral infections.
resultsWe included 3678 visits; 1725 (46.9%) infants tested positive for respiratory viruses. Compared with viral-negative infants, respiratory viral-positive infants had a lower prevalence of UTIs (4.4% [95% CI 3.5-5.6%] vs 12.5% [95% CI 11.0-14.2%]) and bacteremia (1.0% [95% CI 0.5-1.8%] vs 3.0% [95% CI 2.1-4.1%]). No respiratory-viral positive infants had bacterial meningitis, whereas 4 viral-negative infants had meningitis. The prevalence of UTIs ranged from 2.2% to 5.2% in infants who tested positive for influenza, respiratory syncytial virus, or SARS-CoV-2, all lower than viral-negative infants. SARS-CoV-2 positive infants had a lower prevalence of bacteremia compared with SARS-CoV-2 negative infants (0.9% [95% CI 0.3-1.9%] vs 3.1% [95% CI 2.0-4.6%]).
conclusionsThe prevalence of bacterial infections is lower in respiratory virus-positive febrile infants aged 61 to 90 days. These findings may help inform use of respiratory viral testing in the evaluation for UTIs, bacteremia, and meningitis in this age group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.